These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 26204670

  • 41. ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas.
    Sato R, Watanabe H, Genma R, Takeuchi M, Maekawa M, Nakamura H.
    Pharmacogenomics; 2010 Dec; 11(12):1743-50. PubMed ID: 21142918
    [Abstract] [Full Text] [Related]

  • 42. Exorcising the specter of nighttime hypoglycemia.
    Scheiner G.
    Diabetes Self Manag; 2012 Dec; 29(1):16, 18-20. PubMed ID: 22482132
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
    Berger W.
    Horm Metab Res Suppl; 1985 Dec; 15():111-5. PubMed ID: 3865878
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Hypoglycemia associated with high doses of sertraline and sulphonylurea compound in a noninsulin-dependent diabetes mellitus patient.
    Takhar J, Williamson P.
    Can J Clin Pharmacol; 1999 Dec; 6(1):12-4. PubMed ID: 10465860
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
    Crawford BA, Perera C.
    Med J Aust; 2004 May 17; 180(10):540-1; author reply 541. PubMed ID: 15139835
    [No Abstract] [Full Text] [Related]

  • 53. [Knack of treatment with oral hypoglycemic drugs in the elderly].
    Komatsu M, Hashizume K.
    Nihon Rinsho; 2006 Jan 17; 64(1):93-8. PubMed ID: 16408454
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Authors' reply to Bosco-Lévy and Salvo.
    Romley JA, Gong C, Jena AB, Goldman DP, Williams B, Peters A.
    BMJ; 2016 Aug 05; 354():i4330. PubMed ID: 27496026
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Oral hypoglycemic agents.
    Ferner RE.
    Med Clin North Am; 1988 Nov 05; 72(6):1323-35. PubMed ID: 3054355
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Balancing risk and benefit with oral hypoglycemic drugs.
    Hamnvik OP, McMahon GT.
    Mt Sinai J Med; 2009 Jun 05; 76(3):234-43. PubMed ID: 19421967
    [Abstract] [Full Text] [Related]

  • 60. [Hypoglycemic accidents during treatment with antidiabetic sulfamides. Apropos of 5 cases of hypoglycemic coma in aged subjects].
    Brogard JM, Kuntzmann F, Touitou D, Dorner M.
    Sem Hop; 1973 Sep 10; 49(37):2461-6. PubMed ID: 4359498
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.